Radical Prostatectomy for Prostate Cancer: Surgical Excellence at Healthcare International
Introduction
At Healthcare International, our urologic oncology
team specializes in radical prostatectomy, the surgical removal of the
prostate gland, offered via open, laparoscopic, or robotic-assisted (RARP)
techniques. We aim not only to eradicate cancer but also preserve quality of
life through meticulous technique and advanced perioperative care.
1. Cancer Control & Long-Term Survival
Radical prostatectomy is a proven curative option for
localized prostate cancer, offering excellent long-term outcomes:
- Cancer-specific
survival approaches 95% over 15 years, with progression-free
survival around 85% in long-term cohort studies.
- Meta-analyses
show that positive surgical margins—a key predictor of recurrence—are
lower with RARP compared to open surgery (RR ≈ 0.63 in pT2 tumours).
- Seven-year
PSA recurrence-free survival is ~81% following RARP, comparable to open
prostatectomy.
2. Minimizing Complications: RARP vs Open vs LRP
- A
network meta-analysis across 62,000+ patients demonstrates RARP yields
fewer major complications, reduced blood loss, lower transfusion rates,
and shorter hospital stays versus open surgery—and is comparable or
superior to laparoscopic prostatectomy (LRP) in continence, potency, and
recovery time.
- A
Swiss national study (8,593 cases) showed surgical complication rates of 10.1%
for RARP, 9.0% for LRP, and 17.1% for open surgery—underscoring
the safety advantages of minimally invasive approaches.
3. Functional Recovery: Incontinence & Erectile Function
Urinary Continence
- At
12 months
post-surgery, 75% of patients used no pads, while 9–16%
still required pads; most regain full control within 3–6 months.
- In
expert centres, continence rates exceed 90% at one year with median
recovery time around 2.7 months.
Erectile Function
- Rates
of potency recovery vary based on nerve-sparing and age: between 11–87%
regain sexual function at 12 months,
with most recovering by ~8 months.
- A
large prospective cohort reported 59.9% impotence at 18+ months;
nerve-sparing surgery significantly improves outcomes (potency ~56–65%
depending on approach).
Rehabilitation & Support
- Pelvic
floor muscle training (PFMT) before and after surgery significantly
accelerates continence recovery and improves outcomes in many men.
- While
many regain function over time, some patients report persistent challenges
with incontinence or erectile dysfunction; however, most still consider
surgery worthwhile given survival benefits.
4. Patient Experiences: Real-Life Perspectives
- “Four
years post‑RALP: cancer gone, but persistent incontinence and loss of
orgasmic sensation. Still, patient values life and survival above
limitations.”
- “At
12 months, still
severe incontinence but continues pelvic rehab. Life changes but
manageable.”
- “By
3 months I was continent, gradually regaining erectile function with
medication. Working full-time and feeling optimistic.”
These narratives highlight the variability of recovery—with
support and rehabilitation, many patients regain majority function.
5. Why Choose Healthcare International?
🎯 Surgical Precision & Experience
- Our
surgeons are highly trained in robotic and laparoscopic techniques,
maximizing chances for nerve-sparing, minimal margins, and swift recovery.
- We
employ evidence-based refinements such as Retzius-sparing approaches,
bladder neck preservation, and posterior reconstruction to enhance early
continence recovery.
🌍 International-Standard Protocols
- Our
approach aligns with global best practices in oncologic and functional
outcome metrics—including pentafecta criteria: negative margins,
continence, potency, minimal complications, and no biochemical recurrence.
🧭 Supportive Rehabilitation
- Comprehensive
preoperative counselling, pelvic floor training, and early rehab support
aim to improve postoperative recovery trajectories and optimize
quality-of-life outcomes.
Summary Table
|
Outcome |
Radical Prostatectomy (Healthcare International) |
|
Cancer control |
~95% cancer-specific survival at 15 years; long-term
PSA-free rates ~80–85% |
|
Positive margin rate |
Lower with RARP (~37% risk reduction for pT2 tumours) |
|
Perioperative complications |
≤10% with robotic/laparoscopic; higher (~17%) in open
surgery |
|
Continence recovery (12 months) |
~75%; >90% with modern reconstruction techniques |
|
Erectile function recovery |
50–60% at 12 months with nerve-sparing; age and
technique-dependent |
|
Functional rehab |
PFMT accelerates recovery; ancillary therapies available
if needed |
|
Patient satisfaction |
Most patients choose surgery again despite functional side
effects |
Conclusion
Radical prostatectomy remains a cornerstone therapy for
localized prostate cancer—offering durable cancer control when performed
optimally. At Healthcare International, we pair advanced surgical
technology with global-standard protocols and multidisciplinary rehabilitation,
ensuring that functional outcomes are as valued as oncologic success.
If you or a loved one is evaluating surgical options for
prostate cancer, Healthcare International is dedicated to guiding you
safely through treatment with precision, support, and respect. Contact us to
discuss your eligibility and personalized recovery plan today.
Comments
Post a Comment